Evidence-based interpretation of liver biopsies

Laboratory Investigation

Volumn 86, Issue 4, 2006, Pages 326-334

  Crawford, James M ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Evidence based medicine; Hepatitis; Hepatopathology; Liver pathology; Steatohepatitis; Surgical pathology

Indexed keywords

ALPHA INTERFERON; RIBAVIRIN;

CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; EVIDENCE BASED MEDICINE; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER DISEASE; MEDICAL DECISION MAKING; MEDICAL LITERATURE; PATHOLOGICAL ANATOMY; PATHOLOGY; PRIORITY JOURNAL; PUBLICATION; REPRODUCIBILITY; REVIEW; STATISTICAL ANALYSIS; VALIDATION PROCESS; VIRUS HEPATITIS;

AUTHORSHIP; BIBLIOMETRICS; BIOPSY; EVIDENCE-BASED MEDICINE; FORECASTING; HEPATITIS, VIRAL, HUMAN; HUMANS; LIVER; PATHOLOGY, CLINICAL; PERIODICALS;

EID: 33645295477     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.3700403     Document Type: Review

References (28)

1. Sackett DL, Rosenberg WMC, Gray JAM, et al. Evidence based medicine: what it is and what it isn't. Br Med J 1996;312:71-72.
2. Reilly BM. The essence of EBM: practising what we teach remains a big challenge. Br Med J 2004;329:991-992.
3. McQueen MJ. Overview of evidence-based medicine: challenges for evidence-based laboratory medicine. Clin Chem 2001;47:1536-1546.
4. Price C. Evidence-based laboratory medicine: supporting decision-making. Clin Chem 2000;46:1041-1050.
5. Isaacs D, Fitzgerald D. Seven alternatives to evidence-based medicine. Oncologist 2001;6:390-391.
6. O'Donnell M. A Sceptic's Medical Dictionary. BMJ Books: London, 1997.
7. Greenhalgh T. Narrative based medicine in an evidence-based world. Br Med J 1999;318:323-325.
8. Sinard JH, Morrow JS. Informatics and anatomic pathology: meeting challenges and charting the future. Hum Pathol 2001;32:143-148.
9. Baker PB, Zarbo RJ, Howanitz PJ. Quality assurance of autopsy face sheet reporting, final autopsy report turnaround time, and autopsy rates: A College of American Pathologists Q-Probes study of 10003 autopsies from 418 institutions. Arch Pathol Lab Med 1996;120:1003-1008.
10. Zarbo RJ. Monitoring anatomic pathology practice through quality measures. Clin Lab Med 1999;19:713-742.
11. Zarbo RJ, Meier FA, Raab SS. Error detection in anatomic pathology. Arch Pathol Lab Med 2005;129:1237-1245.
12. Raab SS, Grzybicki DM, Zarbo RJ, et al. Anatomic pathology databases and patient safety. Arch Pathol Lab Med 2005;129:1246-1251.
13. Raab SS, Grzybicki DM, Janosky JE, et al. Clinical impact and frequency of anatomic pathology errors in cancer diagnoses. Cancer 2005;104:2205-2213.
14. Wright Jr TC, Cox JT, Massad LS, et al. 2001 Consensus guidelines for the management of women with cervical cytological abnormalities. J Am Med Assoc 2002;287:2120-2129.
15. Marchevsky AM, Wick MR. Evidence-based medicine, medical decision analysis, and pathology. Hum Pathol 2004;35:1179-1188.
16. Reuben A. Where are the gnomes of yesteryear? Hepatology 2002;35:1554-1557.
17. Crawford JM, Tykocinski ML. Pathology as the enabler of human research. Lab Invest 2005;85:1058-1064.
18. Demetris AJ, Seabert EC, Batts KP, et al. Reliability and predictive value of the national institute of diabetes and digestive diseases and kidney diseases liver-transplantation database nomenclature and grading system for cellular rejection of liver allografts. Hepatology 1995;21:408-416.
19. Durack DT. The weight of medical knowledge. N Engl J Med 1978;298:773-775.
20. Madlon-Kay DJ. The weight of medical knowledge:still gaining. N Engl J Med 1989;321:908.
21. Varotti G, Ramacciato G, Ercolani G, et al. Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: a multicentric study on 393 cirrhotic resected patients. EJSO 2005;31:760-767.
22. Toyoda H, Kumada T, Kiriyama S, et al. Comparison of the usefulness of three staging systems for hepatocellular carcinoma (CLIP, BCLC, and JIS) in Japan. Am J Gastroenterol 2005;100:1764-1771.
23. Pawlik TM, Delman KA, Vauthey JN, et al. Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transplant 2005;11:1086-1092.
24. Duarto RF, Delgado J, Shaw BE, et al. Histologic features of the liver biopsy predict the clinical outcome for patients with graft-versus-host disease of the liver. Biol Blood Marrow Transplant 2005;11:805-813.
25. Harrison SA, Brunt EM, Qazi RA, et al. Effect of significant histologic steatosis or steatohepatitis on response to antiviral therapy in patients with chronic hepatitis C. Clin Gastroenterol Hepatol 2005;3:604-609.
26. Kleiner DE. The liver biopsy in chronic hepatitis C: a view from the other side of the microscope. Semin Liver Dis 2005;25:52-64.
27. van Dekken H, Verhoef C, Wink J, et al. Cell biological evaluation of liver cell carcinoma, dysplasia and adenoma by tissue micro-array analysis. Acta Histochemica 2005;107:161-171.
28. Parent R, Beretta L. Proteomics in the study of liver pathology. J Hepatol 2005;43:177-183.